Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disease of enigmatic origin with no established cure. Its constellation of symptoms has silently ruined the lives of millions of people around the world. A plethora of hypotheses have been vainly investigated over the past few decades,...
Main Authors: | Arnaud Germain, David Ruppert, Susan M. Levine, Maureen R. Hanson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/8/4/90 |
Similar Items
-
Insights into Metabolite Diagnostic Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
by: Emi Yamano, et al.
Published: (2021-03-01) -
Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
by: Santa Rasa, et al.
Published: (2018-10-01) -
A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID)
by: Teilah Kathryn Huth, et al.
Published: (2020-05-01) -
Comprehensive Circulatory Metabolomics in ME/CFS Reveals Disrupted Metabolism of Acyl Lipids and Steroids
by: Arnaud Germain, et al.
Published: (2020-01-01) -
Experiences of Living with Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
by: Victoria Strassheim, et al.
Published: (2021-02-01)